PIVKA-Ⅱ在肝细胞癌诊断及预后判断中的作用

李俊利; 尚佳; 宁会彬; 郭恩恩; 何佳

doi:10.3969/j.issn.1001-5256.2017.01.040

PIVKA-Ⅱ在肝细胞癌诊断及预后判断中的作用

DOI: 10.3969/j.issn.1001-5256.2017.01.040

郑州大学人民医院

基金项目:

河南省科技厅基础与前沿技术研究项目(142300410372)；

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2337
- HTML全文浏览量: 49
- PDF下载量: 444
- 被引次数: 0
出版历程
- 出版日期: 2017-01-20

Role of serum abnormal prothrombin protein induced by vitamin K absence or antagonist-Ⅱ in development and progression of hepatocellular carcinoma

The People′s Hospital of Zhengzhou University, Zhengzhou 450000, China

Research funding:

摘要

摘要:
肿瘤标志物早期诊断对肝细胞癌（HCC）患者长期生存预后非常重要。阐述了血清异常凝血酶原维生素K缺乏或拮抗剂Ⅱ诱导的蛋白（PIVKA-Ⅱ）在HCC早期诊断、预后评估和复发预测中的价值,发现其敏感度和特异度较高,与AFP联合能明显提高HCC的早期诊断率。认为动态检测PIVKA-Ⅱ水平变化能够较好地协助临床正确评价HCC的发生、发展、浸润转移和复发,可以作为HCC预后的一个重要指标。
- 癌,肝细胞 /
- PIVKA-Ⅱ /
- 综述
Abstract:
Early diagnosis of hepatocellular carcinoma( HCC) using tumor markers is very important for long- term survival. This article elaborates on the value and high sensitivity and specificity of protein induced by vitamin K absence or antagonist- Ⅱ( PIVKA- Ⅱ) in the early diagnosis,prognostic evaluation,and recurrence prediction of HCC. Its combination with alpha- fetoprotein can significantly increase the early diagnostic rate of HCC. It is pointed out that dynamic measurement of PIVKA- Ⅱ level can assist the correct evaluation of the development,progression,invasion / metastasis,and recurrence of HCC and can be used as an important marker for the prognosis of HCC.
- carcinoma /
- hepatocellular /
- protein induced by vitamin K absence or antagonist Ⅱ

HTML全文

参考文献(34)

[1] PARKIN DM,BRAY F,FERLAY J,et al.Global cancer statistics,2002[J].CA Cancer J Clin,2005,55(2):74-108.

[2]EL-SERAG HB,RUDOLPH KL.Hepatocellular carcinoma:epidemiology and molecular carcinogenesis[J].Gastroenterology,2007,132(7):2557-2576.

[3]ZHAO HZ,QIQI G.Clinical analysis of 207 cases with primary hepatocellular carcinoma[J/CD].Clin J Exp Clin Infect Dis:Electronic Edition,2015,7(3):89-91.(in Chinese)赵海珍,其其格.207例属发性肝细胞癌患者临床分析[J/CD].中国肝脏病杂志:电子版,2015,7(3):89-91.

[4]ZHU MY,CHEN J,ZHANG XX.Research advances in serum biomarkers for early diagnosis of hepatocellular carcinoma[J].J Clin Hepatol,2014,30(10):1091-1093.(in Chinese)朱明玉,陈洁,张欣欣.肝细胞癌早期诊断血清学标志物的研究进展[J].临床肝胆病杂志,2014,30(10):1091-1093.

[5]YANG XX,MA H.Research advances in tumor markers of hepatocellular carcinoma[J].J Clin Hepatol,2016,32(4):812-815.(in Chinese)杨霄霄,马红.肝细胞癌肿瘤标志物的研究进展[J].临床肝胆病杂志,2016,32(4):812-815.

[6]KAWANO Y,SASAKI A,KAI S,et al.Short-and long-term outcomes after hepatic resection for hepatocellular carcinoma with concomitant esophageal varices in patients with cirrhosis[J].Ann Surg Oncol,2008,15(6):1670-1676.

[7]STEFANIUK P,CIANCIARA J,WIERCINSKA-DRAPALO A.Present and future possibilities for early diagnosis of hepatocellular carcinoma[J].World J Gastroenterol,2010,16(4):418-424.

[8]NGUYEN MH,GARCIA RT,SIMPSON PW,et al.Racial differences in effectiveness of alpha-fetoprotein for diagnosis of hepatocellular carcinoma in hepatitis C virus cirrhosis[J].Hepatology,2002,36(2):410-417.

[9]KANG KH,KIM JH,KANG SH,et al.The influence of alcoholic liver disease on serum PIVKA-II levels in patients without hepatocellular carcinoma[J].Gut and Liver,2015,9(2):224-230.

[10]TRUONG BX,YANO Y,VAN VT,et al.Clinical utility of protein induced by vitamin K absence in patients with chronic hepatitis B virus infection[J].Biomed Rep,2013,1(1):122-128.

[11]LIAO YQ,SONG Q.Application of PIVKA-Ⅱdetection in early diagnosis of hepatocellular carcinoma[J].Shaanxi J Med Lab Sci,2000,15(4):29.(in Chinese)廖远泉,宋璆.PIVKA-Ⅱ检测应用于肝细胞癌的早期诊断[J].陕西医学检验,2000,15(4):29.

[12]LIM TS,KIM DO Y,HAN KH,et al.Combined use of AFP,PIVKA-Ⅱ,and AFP-L3 as tumor markers enhances diagnostic accuracy for hepatocellular carcinoma in cirrhotic patients[J].Scand J Gastroenterol,2016,51(3):344-353.

[13]POTN,CAUCHY F,ALBUQUERQUE M,et al.Performance of PIVKA-Ⅱfor early hepatocellular carcinoma diagnosis and prediction of microvascular invasion[J].J Hepatol,2015,62(4):848-854.

[14]VIGGIANI V,PALOMBI S,GENNARINI G,et al.Protein induced by vitamin K absence or antagonist-Ⅱ(PIVKA-Ⅱ)specifically increased in Italian hepatocellular carcinoma patients[J].Scand J Gastroenterol,2016,51(10):1257-1262.

[15]ZHU Y,WANG H,WANG HJ,et al.Study on the significance of serum PIVKA-Ⅱin diagnosis of hepatocellular carcinoma[J].J Clin Exp Med,2014,13(7):513-516.(in Chinese)朱宇,王海,王宏洁,等.血清PIVKA-Ⅱ在HCC诊断中的应用[J].临床和实验医学杂志,2014,13(7):513-516.

[16]LIN YY,CHEN Y,CHEN YS,et al.Clinical value of the abnormal prothrombin PVKIA-Ⅱin detection of hepatocellular carcinoma[J].Curr Immunol,2015,35(4):328-333.(in Chinese)林莺莺,陈燕,陈岩松,等.血清异常凝血酶原(PIVKA-Ⅱ)检测在肝细胞癌中的临床价值[J].现代免疫学,2015,35(4):328-333.

[17]MITA Y,AOYAGI Y,YANAGI M,et al.The usefulness of determining des-gamma-carboxy prothrombin by sensitive enzyme immunoassay in the early diagnosis of patients with hepatocellular carcinoma[J].Cancer,1998,82(9):1643-1648.

[18]CHEN XH,CUI RT,LI YM,et al.The diagnostic value of the des-gamma carboxy prothrombic caused by the vitamin K absence in the hepatic carcinom[J].Chin J Clin Gastroenterol,2002,14(4):156-159.(in Chinese)陈小红,崔儒涛,李仪梅,等.PIVKA-Ⅱ在肝细胞癌诊断中的价值[J].临床消化病杂志,2002,14(4):156-159.

[19]ZHENG HL,ZHAO R,LI DP,et al.Utility of DCP and AFP in diagnosis of primary liver cancer[J].Chin J Gen Prac,2016,14(1):29-31.(in Chinese)郑海伦,赵睿,李大鹏,等.肿瘤标志物DCP和AFP在原发性肝癌中的诊断价值[J].中华全科医学,2016,14(1):29-31.

[20]SEO SI,KIM HS,KIM WJ,et al.Diagnostic value of PIVKA-Ⅱand alpha-fetoprotein in hepatitis B virus-associated hepatocellular carcinoma[J].World J Gastroenterol,2015,21(13):3928-3935.

[21]CUI R,HE J,ZHANG F,et al.Diagnostic value of protein induced by vitamin K absence(PIVKAⅡ)and hepatoma-specific band of serum gamma-glutamyl transferase(GGTⅡ)as hepatocellular carcinoma markers complementary to alpha-fetoprotein.[J].Br J Cancer,2003,88(12):1878-1882.

[22]YAO DF,HUANG ZW,CHEN SZ,et al.Diagnosis of hepatocellular carcinoma by quantitative detection of hepatoma-specific bands of serum gamma-glutamyltransferase[J].Am J Clin Pathol,1998,110(6):743-749.

[23]FUJIYAMA S,TANAKA M,MAEDA S,et al.Tumor markers in early diagnosis,follow-up and management of patients with hepatocellular carcinoma[J].Oncology,2002,62(Suppl 1):57-63.

[24]LOK AS,STERLING RK,EVERHART JE,et al.Des-gammacarboxy prothrombin and alpha-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma[J].Gastroenterology,2010,138(2):493-502.

[25]ZAKHARY NI,KHODEER SM,SHAFIK HE,et al.Impact of PIVKA-Ⅱin diagnosis of hepatocellular carcinoma[J].J Adv Res,2013,4(6):539-546.

[26]NAKAO A,TANIGUCHI K,INOUE S,et al.Usefulness of simultaneous determination of alpha-fetoprotein and des-gammacarboxy prothrombin in hepatocellular carcinoma[J].Semin Surg Oncol,1996,12(3):160-163.

[27]IMAMURA H,MATSUYAMA Y,MIYAGAWA Y,et al.Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma[J].Br J Surg,1999,86(8):1032-1038.

[28]TOYODA H,KUMADA T,KANEOKA Y,et al.Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC[J].J Hepatol,2008,49(2):223-232.

[29]KANG SH,KIM DY,JEON SM,et al.Clinical characteristics and prognosis of hepatocellular carcinoma with different sets of serum AFP and PIVKA-Ⅱlevels[J].Eur J Gastroenterol Hepatol,2012,24(7):849-856.

[30]TAKAHASHI S,KUDO M,CHUNG H,et al.PIVKA-Ⅱis the best prognostic predictor in patients with hepatocellular carcinoma after radiofrequency ablation therapy[J].Oncology,2008,75(Suppl 1):91-98.

[31]NANASHIMA A,MORINO S,YAMAGUCHI H,et al.Modified CLIP using PIVKA-Ⅱfor evaluating prognosis after hepatectomy for hepatocellular carcinoma[J].Eur J Surg Oncol,2003,29(9):735-742.

[32]KIM JM,HYUCK C,KWON D,et al.Protein induced by vitamin K antagonist-Ⅱ(PIVKA-Ⅱ)is a reliable prognostic factor in small hepatocellular carcinoma[J].World J Surg,2013,37(6):1371-1378.

[33]PARK H,PARK JY.Clinical significance of AFP and PIVKA-Ⅱresponses for monitoring treatment outcomes and predicting prognosis in patients with hepatocellular carcinoma[J].Biomed Res Int,2013,2013:310427.

[34]WANG BL,TAN QW,GAO XH,et al.Elevated PIVKA-Ⅱis associated with early recurrence and poor prognosis in BCLC 0-A hepatocellular carcinomas[J].Asian Pac J Cancer Prev,2014,15(16):6673-6678.

施引文献

资源附件(0)

访问统计